Key result
Serum adiponectin levels were significantly decreased in patients with diabetic retinopathy (2.8 ng/ml) but significantly increased in those with diabetic nephropathy (68.6 ng/ml) compared to healthy controls (13.3 ng/ml).
Cross-Sectional (n=75)
No
Serum adiponectin levels are decreased in diabetic retinopathy but increased in diabetic nephropathy, suggesting it may serve as a prognostic marker for specific microvascular complications in type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Adiponectin may differentiate diabetic microvascular complications; hypothesis-generating and should not yet change practice.
Soher A. Mohammed Ismail (2016) conducted a cross-sectional in Type 2 diabetes mellitus (n=75). Diabetic microvascular complications (retinopathy and nephropathy) vs. Healthy controls and uncomplicated type 2 diabetes was evaluated on Serum adiponectin concentration. Serum adiponectin levels were significantly decreased in patients with diabetic retinopathy (2.8 ng/ml) but significantly increased in those with diabetic nephropathy (68.6 ng/ml) compared to healthy controls (13.3 ng/ml).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: